Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
EFFECTOR Therapeutics, Inc.. Thank you for visiting the website for eFFECTOR Therapeutics, Inc. (“Company”), a clinical stage biopharmaceutical company formerly based in Solana Beach, CA. The Company is no longer operating. Any questions may be submitted by email to: [email protected].
News
Effector Therapeutics: The Final Chapter for Shareholders
Effector Therapeutics US28202V1089
Read more
Report
eFFECTOR Therapeutics Announces it will Wind Down Operations as it Seeks Strategic Alternatives and Expects to be Delisted from Nasdaq
--eFFECTOR Therapeutics, Inc. today announced that the Company has terminated its employees and will wind down it operations, including seeking potential strategic alternatives for the Company' s development programs. Further, as previously disclosed, the
Read more
Report
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced a co
Read more
Report
